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ABSTRACT: Metal-based nanoparticles (NPs), are currently used in many application fields including
consumer products, pharmaceuticals, and biomedical treatments. In spite to their wide applications, an
in-depth study of their potential toxic effects is still lacking. The aim of the present research was to inves-
tigate the potential initiator or promoter-like activity of different metallic NPs such as gold, iron, cobalt,
and cerium using the Balb/3T3 two-stage transformation assay. The results indicated that all the selected
metallic NPs, except for cobalt, when used as initiators did not induce any transformation in Balb/3T3 cell
line. Moreover, Au and Fe3O4 NPs, when used in place of the tumor promoter treatment TPA, increased
significantly the number of Foci/dish as compared to the MCA treatment alone. The number of Foci/dish
was 2.6 for Au NPs and 2.13 for Fe3O4 ones, similar to those obtained by the positive control treatment
(MCA 1TPA), whereas 1.27 for MCA treatment alone. On the contrary, CeO2 NPs did not show any differ-
ence in the number of Foci/dish, as compared to MCA alone, but it decreased the number of foci by 65%
in comparison to the positive control (MCA 1TPA). As expected, cobalt NPs showed an increased cyto-
toxicity and only a few surviving cells were found at the time of analysis showing a number of Foci/dish of
0.13. For the first time, our data clearly showed that Au and Fe3O4 NPs act as promoters in the two stage
transformational assay, suggesting the importance to fully investigate the NPs carcinogenic potential with
different models. VC 2014 Wiley Periodicals, Inc. Environ Toxicol 31: 509–519, 2016.
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INTRODUCTION
In recent years, much attention has been paid to nanotech-
nology and its new wide range of potential applications. Par-
ticularly, metal-based NPs such as gold, iron, cobalt, and
cerium, thanks to their variety and characteristics, are
already being used in several application fields including
consumer products, pharmaceuticals, and biomedical treat-
ments (Nohynek et al., 2007, Wang et al., 2008).
Gold NPs are already being tested as a drug delivery car-
rier (Chen et al., 2008, Boisselier and Astruc, 2009) to cure
leukaemias and autoimmune diseases (i.e., rheumatoid
arthritis, lupus erythematosus). Super-paramagnetic Iron
Oxide NPs (Fe3O4, SPION) are being tested as enhancers of
contrast in nuclear magnetic resonance imaging, as drug
delivery carriers and even as a multifunctional platform for
the inhibition of bacteria biofilm during the infection process
(Petri-Fink and Hofmann, 2007; Ravizzini et al., 2009; Bur-
tea et al., 2011; Durmus et al., 2013). The biomedical special
interest of cerium NPs is represented by their radio protec-
tive effect in radiotherapy of cancer diseases. The unique
property of cerium NPs is represented by the ability to
exceed all traditional antioxidants and to exert radio
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protective properties in biological media (Hirst et al., 2011;
Shcherbakov et al., 2011; Wason and Zhao, 2013). Cerium
NPs are now even being studied as possible neuro protectors
after ischemia process (Estevez et al., 2011).
Cobalt NPs are being tested as a noninvasive method for
eradicating cancer cells by using thermal therapy and radio
frequency radiation (Xu et al., 2008), as components of glu-
cose biosensors or in ophthalmic procedures (Rutnakornpi-
tuk et al., 2002). Since the constant increase of metallic
NPs in biomedical applications, several studies have been
already carried out to evaluate the possible cytotoxicity of
these new materials. However, few studies have focused on
their carcinogenic potential. The ability of NPs to stimulate
target cells to produce reactive oxygen species in target
cells might induce an increased genetic instability that
could be associated with cancer development (Shuo et al.,
2014).
Ponti et al. in 2009 showed the genotoxicity of cobalt
NPs (Co NP 100–500 nm) as compared to cobalt ions
(Co21). They found that Co NPs are able to induce geno-
toxic effects in human isolated leukocytes although their
mechanisms of action are not very clear. The high variability
in the genotoxic effects seems to be related to their size and
internalization process and was found to be less efficient
than cobalt ions one. Additional in vitro studies concerning
the concurrent cytotoxicity and transforming capacity of Co
NPs in a Balb/3T3 cell line have revealed that such NPs can
gradually dissolve in culture media releasing Co21 (Papies
et al., 2007).
Recently, it has been shown that iron oxide NPs (Fe3O4-
Magnetite) were able to induce a dose dependent cytotoxic
effect in human skin epithelial A431 cells and in A549 lung
epithelial cells. Moreover, after 24 h of exposure, NPs were
able to exert genotoxic effect, as measured by the Comet
assay (Ahamed et al., 2013).
These results prompted us to investigate the potential ini-
tiator or promoter-like activity of different metallic NPs
such as gold, iron, cobalt, and cerium. The two-stage trans-
formation assay mimics an initiation/promotion regimen of
multistage carcinogenesis in vivo (Mondal et al., 1976; Bor-
eiko, 1986) and therefore appears to be an appropriate in




Four different spherical types of NPs were purchased in dust
form: Au (50–100 nm), Co (28 nm), Fe3O4 (20–50 nm),
CeO2 (15–30 nm) NPs (Nanostructured & Amorphous Mate-
rials, Houston, TX). The NPs were depirogenated for 100
min at 190C and suspended in phosphate buffered saline
(PBS) (GIBCO Invitrogen, Karlsruhe, Germany) at pH 7.5,
then sonicated in a Branson 3510 Ultrasonic bath (Branson
Ultrasonics, Danbury, CT) for 20 min and filtered through a
0.2 micron filter. Strong vortexing before each test to avoid
micro clusters formation and NPs aggregation was carried
out. Figure 1 shows the morphology of the different NPs by
means of a Field Emission Gun Environmental Scanning
Electron Microscope (FEG-ESEM) (Quanta 250, FEI, The
Netherlands). The observations occurred at low vacuum,
from 30 to 8 keV, in secondary and backscattered mode, at
10 mm of working distance (WD). An Energy Dispersive X-
ray Spectroscopy (EDS) (EDAX, USA) detector, coupled to
FEG-ESEM, was used to identify the chemical composition
of the NPs.
The NPs suspensions were characterized using the fol-
lowing techniques:
1. Zeta Potential (Z-Potential) (Malvern ZetaSizer Nano ZS, UK)
operating at a light source wavelength of 532 nm and a fixed
scattering angle of 173 to determine changes in the surface
state and charge.
2. Dynamic light scattering (DLS) (Malvern Zetasizer Nano ZS,
UK) to define the hydrodynamic diameter of the NPs
dispersion.
Each solution was analyzed at 25C, in triplicate. Hydro-
dynamic diameters were calculated using the internal soft-
ware analysis from the DLS, intensity-weighted particle size
distribution and each measurement was the average of 20
data sets acquired for 10 s each (Table I).
Cell Culture
BALB/3T3 clone A31-1-1 cells were provided by the Istituto
Zooprofilattico Sperimentale (IZSBS, Brescia, Italy). The
defrozen cell cultures assays were always maintained in a
subconfluent state (less than 80% of confluence). Cells were
cultured using Dulbecco’s Modified Eagle’s Medium
(DMEM) supplemented with 10% FBS (Australian origin)
and 0.5% (v/V) Penicilline-Streptomicine (Invitrogen, Italy).
Two-stage transformation assays were performed using a
mix of Eagle’s minimal essential medium (EMEM), and
Ham F-12 medium and ITES (5000 mg bovine pancreas
insulin, 10,000 mg human transferrin, 1530 mg ethanolamine,
and 4.3 mg sodium selenite in a vial) (Invitrogen, Italy). Final
medium was prepared by adding an equal volume of EMEM
and Ham F-12 medium with 1% ITES and 5% FBS. Cell
cultures were maintained in standard conditions (95%
humidity, 5% CO2, 37
C).
CFE and XTT Assays
To assess NPs toxicity on BALB/3T3 clone A31-1-1 cells, a
colony-forming efficiency (CFE) and XTT cell viability
assay were performed with different NPs concentrations. For
the CFE assay, cells were plated in 60 mm petri dishes with
5 mL of DMEM medium at the density of 5 3 104 cells/
dish. Twenty-four-hours after seeding the cells were counted
(B€urcker chamber) and treated with each type of NPs at the
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concentrations of 1, 10, 50, and 100 mM that corresponds to
0.2, 2, 10, 20 mg/mL, respectively. NPs concentrations in the
growth media were obtained by adding a given amount of
particles to the medium. Cells plated in petri dishes without
NPs were the negative control, while cell exposed to 0.125%
(w/v) phenol (Sigma Aldrich, St Louis, MO), were the posi-
tive control. The viability of the cells was preliminarily
assessed by observing the degree of their adhesion to the
substratum and their morphology after 24 h of incubation
time with the NPs. Then, the cells were stained with Giemsa
(Sigma-Aldrich, St. Louis, MO) for the microscopic evalua-
tion (Optical microscope, Nikon TMS, Japan). After 48 and
72 h, the total number of cells was counted and the ability to
form colonies (groups of at least 16 cells) was assessed.
For XTT assay, cells were plated in 96 wells microplates
(NUNC, USA) at a concentration of 7 3 103 cells/well in a
volume of 100 mL of medium. After 3 h of incubation time
the cells were treated using the four types of metallic NPs at
different concentrations (1, 10, 50, and 100 mM). After 48 or
72 h of NPs contact, 50 mL of XTT labeling mixture solution
was added to each well. After 8 h the plates were analyzed
using a spectrophotometer (Multiskan RC, ThermoLabsys-
temsTM, Finland) at a wavelength of 492 nm. Nontreated
cells were used as negative control, while cells treated with
PBS acted as solvent control and cells treated using 0.125%
(w/v) phenol served as positive control. Results were
expressed as an average of five independent experiments.
NPs spectrophotometrical interference was estimated per-
forming preliminary readings with NPs and PBS.
Two-Stage Cell Transformation Assay
The two-stage cell-transformation assay is based on BALB/c
3T3 cells treatment with a sub-threshold dose of a tumor ini-
tiator 3-methylcholanthrene (MCA) at the beginning of
TABLE I. Mean size distribution (nm) 6 SD of NPs after
PBS suspension at different time points
NPs
Average Diameter (nm) in PBS
24 h 48 h 72 h PDI
Au 190 6 10.1 187 6 20.1 180 6 28.6 1
Co 122 6 11.3 141 6 11.2 134 6 12.4 0.81
Fe3O4 161 6 12.4 159 6 15.7 178 6 11.7 0.77
CeO2 171 6 23.1 175 6 19.8 188 6 17.3 0.89
Poly Dispersivity Index (PDI) value has been included.
Fig. 1. FEG-ESEM images of suspended NPs. (A) Fe3O4, (B) CeO2, (C) Au, and (D) Co.
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cultivation and then with a tumor promoter 12-O-
Tetradecanoylphorbol 13-acetate (TPA) to induce preneo-
plastic foci. This type of two stage cell transformation (ini-
tiation and promotion) assay in vitro is similar to two-stage
carcinogenesis in vivo tests (Kuroki and Sasaki, 1985; Sakai
and Fujiki, 1991). The two stage transformation assay used
to test the NPs was based on the improved method proposed
by Kajiwara et al., 1997. In particular, it was used a special
medium supplemented with a mixture of insulin, transferrin,
ethanolamine, and sodium selenite (ITES) and a low concen-
tration of fetal bovine serum (FBS). It was demonstrated that
this medium together with MCA1TPA treatment caused
high frequency transformation with foci appearing after 45
days instead of the 90 days required by the original protocol.
NPs were tested in various combinations as potential initia-
tors, promoters or both: NPs at the concentration of 10 mM
were used with/without MCA or TPA following the two-
stage protocol (Fig. 2).
Actively growing cells were seeded at a density of 5 3
104 cells/dish in 5 mL of DMEM culture medium. Twenty-
four-hours after seeding the cells were treated with/without
the tumor initiator MCA at the concentration of 0.5 mgr/mL
with/without NPs. After three days the medium was changed
and ITES cell medium was added for another three days.
Cells were then treated with/without the tumor promoter
TPA at the concentration of 300 ngr/ml with/without NPs,
for two weeks. After two weeks cells were normally seeded
with ITES medium for another four weeks. After foci forma-
tion cells were fixed with 100% methanol and stained with a
2 mL of GIEMSA 1:10 solution. Tumor foci were manually
scored for morphological transformation under stereomicro-
scope as described by the International Agency for Cancer
Research (IARC) Working Group (IARC/NCI/EPA, 1985).
To evaluate culture conditions, plating efficiency (PE, calcu-
lated as the mean of colonies in CFE/dish 3 100) and Sur-
vived cells (SC, calculated as the total number of cells 3
PE/100) were estimated.
Electron Microscopy Analysis
The NPs uptake by cells was investigated by means of Scan-
ning and Transmission Electron Microscopy (STEM and
TEM). For the TEM (Jeol 1200’ EXII, Japan) observations,
ultra-thin sections (70-nm thick) were cut with an ultracut
microtome (Ultracut Reichert, USA), collected on 150-mesh
copper grids and stained with uranyl acetate and lead citrate.
TEM observations were performed using EDS analyses
(Inca 100, Oxford) to check the NPs chemical composition.
For STEM observations (FEG-ESEM Quanta 250, FEI
Company, the Netherlands), cells were cultured at a density
of 5 3 105 in a 75 cm2 flask (Corning Incorporated, NY)
with 20 mL of complete culture medium. Cells were
exposed to NPs at the concentration of 10 mM for 48/72 h.
After exposure, the medium was removed and cells were
washed with PBS and then detached from the substrate using
trypsin (Sigma–Aldrich, Italy) and centrifugated at
1000 rpm for 5 min. The cell pellets were thoroughly
washed with PBS buffer and fixed in a solution of 2.5% (v/
v) (Sigma–Aldrich, Italy) for 90 min at 4C. They were then
rinsed with PBS and postfixed in 1% (v/v) osmium tetroxide
aqueous solution (Sigma–Aldrich, Italy) for 1 h. Cells were
later dehydrated in an ascending graded series of ethanol
(30, 60, 70, 90, and 100%, v/v), and embedded in epoxy
resin (FlukaBioChemika, Switzerland). The resin was poly-
merized at 60C for 48 h. The ultra-thin sections (60–70 nm)
obtained with an ultracut microtome (Ultracut Reichert,
USA) mounted on a copper grid were analyzed under the
FEG-ESEM microscope.
The same microscope was used to analyze the Type III
foci obtained after treatments in the two-stage transforma-
tion assay. Cells were cultured in 60 mm petri dishes in
which a 13-mm diameter plastic coverslip (Thermanox Plas-
tic Coverslips, NUNC, USA) was placed, with 5 mL of
DMEM medium at the density of 5 3 104 cells/dish. Cells
were treated with/without NPs at the dilution of 10 mM for
Fig. 2. Scheme of two-stage transformation assay. Initiation phase, day 1–7. On day 1, subconfluent Balb/3T3 cell culture
was treated with MCA 0.5 lg/mL (positive initiator) or metal NPs (10 lM of Fe3O4/CeO2/Au/Co NPs) as initiator stimuli and
reseeded in DMEM medium supplemented with 10% FBS. On day 4 medium was changed. Promotion started on day 7 and
ended on day 25. In promotion phase, cells were cultured in DMEM medium supplemented with 5% FBS and 1% ITES. On
days 7, 11, and 14 cells were treated with TPA 300 ng/mL (positive promoter) or metal NPs (2.5 lM of Fe3O4/CeO2/Au/Co
NPs) as promoter stimuli to reach the final 10 lM dilution. After two weeks cells were normally seeded with ITES medium for
another four weeks.
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48/72 h with/without MCA or TPA as described in two-
stage transformation assay. Thereafter, treated and untreated
(control) cells were extensively washed with PBS buffer,
fixed in a 4% glutaraldehyde (solution Sigma-Aldrich, Italy)
for 1 h and dehydrated in ascending concentration solutions
of ethanol (70, 90, and 100%) for 10 min. The cells were
then observed in low vacuum modality in order to preserve
cells samples without further treatments or manipulations.
Statistical Analyses
In cytotoxicity assays, the total colonies data after NPs treat-
ment were statistically analyzed as mean of three independ-
ent experiments (5 replicates each) with standard deviation
and expressed as CFE% respect the negative control. Data
were analyzed using one-way ANOVA model with Dun-
nett’s comparative test. Two-stage cell transformation assay
was performed in three independent experiments (5 repli-
cates each). Experimental data were analyzed by one-way
ANOVA with Bonferroni’s multiple comparison test. Graph-
Pad Prism 5 software was used to elaborate graphs and data.




The NPs characterization was performed using a combina-
tion of STEM, TEM, DLS, and Zeta-potential techniques.
The size distribution of NPs after PBS suspension was veri-
fied with DLS techniques at different time points. Results
show that NPs once suspended form larger aggregates with
diameters ranging from 122 6 15.1 nm (Co) to 190 6 10.1
(Au) nm. NPs suspensions remain rather stable after 48 and
72 h (Table I). The presence of a single peak in the size dis-
tribution confirmed that NPs were monodispersed. TEM
results of gold, cobalt, iron oxide, and cerium oxide NPs
confirmed the NPs tendency to aggregate and to form clus-
ters. Z-potential measurements of the suspensions indicated
values of: 210 mV for Au NPs, 28.2 mV for Co NPs,
210.6 mV for Fe3O4 NPs, and 28,4 mV for CeO2 NPs.
Cytotoxicity
The NPs cytotoxicity was evaluated on Balb/3T3 cell by
colony forming efficiency (CFE) assay and by XTT assay.
Cells were exposed to NPs at concentrations ranging from
1 to 100 mM and at the exposure times of 48 and 72 h. We
focused our attention on 72 h exposure time, since no sig-
nificant difference in cytotoxicity was detected between
the two times of exposure (data not shown). The results
obtained by CFE assay (Fig. 3) showed toxicity for all
types of NPs at the 50 mM concentration. Cobalt NPs
showed greater toxicity by decreasing the number of colo-
nies from 32% to 48% even at lowest dilutions (1 and 10
mM) as compared to the negative control. At the concentra-
tion of 1 or 10 mM Au, Fe3O4 and CeO2 NPs did not exert
significant cytotoxicity on Balb/3T3 at all times tested.
Using XTT assay on Balb/3T3 to evaluate cell viability at
the same concentrations and exposure times, we observed
that Au, Fe3O4, and CeO2 NPs were able to decrease sig-
nificantly the cell viability by over 18% only at 100 mM
concentration. Cobalt NPs on the contrary showed a reduc-
tion of nearly 98%, so affecting the cell viability even at
the lowest concentration tested (1 mM) (Fig. 3).
NPs Carcinogenic Potential
To evaluate the NPs carcinogenicity, the two-stage cell
transformation was selected using the 10 mM NPs concentra-
tion on the base of the toxicological results of the CFE and
XTT assays. In fact, 10 mM is the maximum concentration
of NPs, which did not show cytotoxic effects (except for Co
NPs) and, at the same time, possessed the best PDI (Poly
Dispersivity Index).
The NPs as initiators alone or in combination with TPA
(NPs 1 TPA), did not produce tumor foci except in the case
of cobalt which, in spite of its toxicity found in XTT and
CFE assays, confirmed a carcinogenic effect on the Balb/
3T3 cells, acting as initiator (Co alone and Co 1 TPA). The
incubation of Balb/3T3 cells with Co NPs alone produced a
number of Foci/dish of 0.2 (Table II). The ability to decrease
cell viability and proliferation did not prevent foci formation
after only three days (72 h) of exposure with a number of
Foci/dish of 1.8 (Table II). Surprising results were obtained
using the NPs in place of the tumor promoter treatment TPA
(MCA 1 NPs). In particular Au and Fe3O4 NPs increased
significantly the number of Foci/dish compared to the MCA
treatment alone (*P< 0.05). The number of Foci/dish was
2.6 for Au NPs and 2.13 for Fe3O4, similar to those obtained
by the positive control treatment (MCA 1 TPA), whereas
1.27 for MCA treatment alone.
Different results were obtained using cerium oxide NPs.
Indeed, the data did not show any difference in the number
of Foci/dish, between the CeO2 NPs administered as tumor
promoter and the MCA alone (Table II). In addition, CeO2
NPs treatment showed a dramatic and significant decrease in
the number of foci (265%,***P< 0.001), when compared
to the positive control (MCA 1 TPA) as reported in Table II.
As expected, cobalt NPs showed an increased toxic effect
due to the prolonged time of exposure (>96 h). In fact, at
the end of the treatment, only a few surviving cells were
found upon contact (CFE 5 51%) showing a number of
Foci/dish of 0.13 with a significant decrease versus MCA
and versus the positive control MCA 1 TPA (*P< 0.05).
Predominantly Type III foci were found after NPs treat-
ments. Type III foci are dense, multilayered, and basophilic,
with a random orientation of cells at the focus edge and
invasion into the monolayer (Fig. 4).
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Fig. 3. Cytotoxicity of NPs (gray histogram) versus negative control (black histogram). Col-
ony forming efficiency (CFE) of Balb/3T3 cells exposed for 48 and 72 h to increasing con-
centration of NPs (1–100 mM). All NPs except cobalt NPs induced cytotoxicity in Balb/3T3
cells at 72 h of exposure at concentration >10 mM. Cobalt NPs were the only particles
exerting a toxic effect even at the 1 mM concentration. Data, mean of three independent
experiments (three replicates each) 6 standard deviation (SD), were analyzed in compari-
son to the solvent control and evaluated by one-way ANOVA and Dunnet post test
(*P< 0.05). XTT cell viability test on Balb/3T3 cells exposed 48 and 72 h confirmed nearly
the same results thus showing decreased cell viability for all NPs except cobalt only at the
100 mM highest concentration. Data, mean of three independent experiments (three repli-
cates each) 6 standard deviation (SD) were analyzed in comparison to the negative control
and evaluated by one-way ANOVA and Dunnet post-test (*P< 0.05).
Nanoparticles Cell Interaction
STEM observations clearly showed a general NPs cellular
internalization. At morphological level, cells looked healthy,
proliferating and well preserved. No evidence of cytoskele-
ton structure changes, cell sufferance, or apoptosis was
found. NPs were found within phagocytic vacuoles or spread
in the cytoplasm. Iron oxide and gold NPs were also found
in close contact to the nuclear area of Balb/3T3 cells as
shown in Figure 5. The Type III foci ESEM observation
revealed a dense, multilayered morphology. In addition, the
ESEM images clearly showed the cell foci invasion into the
monolayer (Fig. 6). In all the images the presence of all
types of NPs in clustered form was found mostly coincident
to the cell foci.
DISCUSSION
In recent years the use of metallic NPs has been widely used
in many different fields, such as the medical-pharmaceutical
industry. Several studies of nanomedicine have shown the
TABLE II. Two-stage transformation assay results after Au, Co, Fe3O4, CeO2 NPs exposure
CFE% PE % Survived Cells No. of Foci Foci/dish
No. of Dishes
Examined
NEG 100 33.33 166,666 0 0 15
MCA 31 10.33 51,666 19 1.27 15
TPA 49 16.33 81,666 0 0 15
MCA1TPA 81 27 135,000 38 2.53 15
Au 99 33 165,000 0 0 15
Fe3O4 95 31,66667 158333.3 0 0 15
CeO2 92 30,66667 153333.3 0 0 15
Co 62 20,66667 103333.3 3 0.2 15
MCA1Au 93 31 155,000 39 2.6 15
MCA1Fe3O4 82 27.33 136,666 32 2.13 15
MCA1CeO2 92 30.66 153,333 17 1.13 15
MCA1Co 51 17 85,000 2 0.13 15
Au1TPA 70 23.33 116,666 0 0 15
Fe3O41TPA 82 27.33 136,666 0 0 15
CeO21TPA 85 28.33 141,666 0 0 15
Co1TPA 51 17 85,000 27 1.8 15
Fig. 4. Foci formation in Balb/3T3 cells after MCA, MCA 1TPA, and MCA 1 NPs treatments. Optical images (340) of type III
foci after (A) Au NPs treatment or (B) Fe3O4 NPs treatment.
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beneficial effects of certain types of NPs for the treatment of
tumors (Wang et al., 2008; Martin et al., 2013), for a selec-
tive transport of the drug to the site of action (Chen et al.,
2008), and to improve the Nuclear Magnetic Resonance
(NMR) imaging (Duguet et al., 2006). However, only
recently, clinical studies have been performed verifying the
metallic NPs potential toxicity. It has been demonstrated an
enhancement of the inflammatory response by NPs in lung
tissues (Zhang et al., 2012; Fariss et al., 2013) and in the
central nervous system (Peters et al., 2006; Block and
Calderon-Garcidue~nas, 2009).
So in order to fulfill the mandatory requirement of ensur-
ing the safety of workers, patients and the consumers/users,
toxicological research with several approaches is fundamen-
tal. In this context, recently, it was shown the carcinogenic
potential of cobalt NPs on cells of murine fibroblasts
Fig. 5. TEM (A, B, C, D) and STEM images (E, F, G, H) of NPs inside the Balb/3T3 cells. Image (A) presence of Fe3O4 nanopar-
ticles inside vacuoles in the nuclear area of a mitotic cell. Image (B) Fe3O4 nanoparticles in the nuclear area of a mitotic cell.
Image (C) nonmitotic cell nucleus with two Au particles micro-clusters. Image (D) Au nanoparticles internalized by the cells.
Images (E, F) CeO2 NPs inside the cell cytoplasm or entrapped into vesicles. Image (H) Co NPs in close contact with the cell
membrane. Image (G) Co NPs inside the cell membrane. On the right side of each panel the EDS spectrum of the NPs is
reported. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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(Balb/3T3) (Ponti et al., 2009). The authors clearly demon-
strate that, in spite of a common toxicity test elicited by Co
NPs and Co21, only Co NPs were able to induce morpholog-
ical transformation and genotoxicity, suggesting that the
toxic mechanisms were mostly triggered by Co NPs. These
findings induced us to evaluate if different NPs were able to
induce cancerogenesis using the two-stage transformational
assay.
We focused our attention on Fe3O4, CeO2, and Au NPs,
for their medical applications as contrast agent in NMR, or
as catalyst and UV adsorbent and tumor hyperthermia
agents.
Co NPs at a 10 mM concentration were selected as refer-
ence cancerogenic compound to perform the two-stage trans-
formational assay; concentration that was able to induce
tumoral foci in Balb/3T3 cells (Ponti et al., 2009).
Really interestingly was the result obtained on the ability
of the selected metal nanoparticles (NPs), to generate and/or
promote tumoral foci in Balb/3T3 cell line. NPs showed dif-
ferent results depending to the respective chemical-physical
properties. Indeed, while Fe3O4, Au, and CeO2 NPs, when
used as tumor initiators, did not give rise to any kind of neo-
plastic transformation, Co NPs was able to induce foci for-
mation, confirming the data by Ponti at al. (Ponti et al.,
2009).
However, the Fe3O4 and Au NPs when tested as a pro-
moters showed a dramatic increase of neoplastic foci, as
compared to MCA alone, reaching values similar to those
obtained by the promoter TPA. The fact that Co NPs was not
able to generate foci as a promoter must be attributable to its
intrinsic cytotoxic activity, which does not allow the cells to
reach the end point of the two stages transformation assay.
Interestingly is the finding regarding the activity of CeO2
NPs. In fact, CeO2 NPs did not alter the number of foci
obtained by MCA alone, but they decrease significantly the
formation of foci when compared to the positive control
(MCA 1 TPA), suggesting a potential antagonism in the pro-
motion of cell transformation. It is known that many factors
are involved in NPs toxicity such as size (the tiny size allows
the cell internalization and a close contact with organelles,
protein, and DNA), morphology, composition, surface
charge, coating, aggregation, or capacity of self- assembly,
capacity of conjugation (strong or weak bonds) with other
components (proteins, lipids, etc.), catalytic properties or
combination with other biological components. In addition,
toxicity is strongly dependent on the bio-distribution capacity
Fig. 6. ESEM images of type III foci after Au-NPs (A) and Fe3O4 NPs (B) treatment as promoter. EDS spectrum (C, D) of the
NPs is reported. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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of the NPs to induce local or systemic problems, on their rate
of elimination and tissue localization and, very important, on
whether the materials used are biodegradable or non-
biodegradable (Medina et al., 2007). Taken into account all
these assumptions, it becomes difficult to identify the molec-
ular mechanisms responsible of the Balb/3T3 transformation
elicited by the selected NPs.
In this context, our results indicate that at least two main
hypotheses can be formulated regarding the morphological
transformation elicited by Fe3O4, Au NPs. The first one
could be related to their intrinsic physical properties, which,
in turn, could interfere with several biochemical and intra-
cellular signaling pathways, such as genotoxic activity
reported for Co NPs (Ponti et al., 2009).
The second one could be related to ions release from the
NPs, which might induce cytotoxicity as in the case of Co21
or inflammation and therefore promotion of cell transforma-
tion. Although the latest hypothesis must be likely true, the
data available in literature on Fe3O4, CeO2 and Au ions, did
not show any carcinogenic activity in contrast to those one
found for Co21 (Lison et al., 2001; Jakupec et al., 2005;
Raymond and Che, 2009; Foy and Labhasetwar, 2011).
Interestingly, in our experiments we noticed that the
tumoral foci were developed mostly in conjunction with the
largest agglomerates of NPs. This NPs agglomerates could
be a sort of scaffold for the engraftment of foci. In this con-
text future studies are planned in order to better understand
the mechanisms of NPs effects in the promotion of neoplas-
tic transformation of cells.
Finally, our data clearly showed, for the first time, that
Au and Fe3O4 NPs act as promoters in the two-stage trans-
formational assay. This important result highlighted more
than ever that it is essential to investigate extensively the
NPs toxicological profiles in different in vitro and in vivo
models, in order to identify any potential impact of NPs on
human health.
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